These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
4. Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer. Finne P; Zhang WM; Auvinen A; Leinonen J; Määttänen L; Rannikko S; Tammela TL; Stenman UH J Urol; 2000 Dec; 164(6):1956-60. PubMed ID: 11061890 [TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker. Mulders TM; Bruning PF; Bonfrer JM Eur J Surg Oncol; 1990 Feb; 16(1):37-41. PubMed ID: 1689677 [TBL] [Abstract][Full Text] [Related]
6. Relationship between prostate size and percent free prostate-specific antigen in patients with operable prostate cancer. Nativ O; Sabo E; Wald M; Halachmi S; Moskovitz B Isr Med Assoc J; 2000 Dec; 2(12):889-91. PubMed ID: 11344767 [TBL] [Abstract][Full Text] [Related]
7. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease. Mikolajczyk SD; Rittenhouse HG Rinsho Byori; 2004 Mar; 52(3):223-30. PubMed ID: 15137320 [TBL] [Abstract][Full Text] [Related]
8. [Tumor markers in prostate cancer--clinical significance and future prospect of prostate specific antigen (PSA)]. Tsuchiya N; Ohyama C; Habuchi T Gan To Kagaku Ryoho; 2005 Feb; 32(2):275-80. PubMed ID: 15751649 [TBL] [Abstract][Full Text] [Related]
9. Circulating PSA-containing macrophages as a possible target for the detection of prostate cancer: a three-color/five-parameter flow cytometric study on peripheral blood samples. Leers MP; Nap M; Herwig R; Delaere K; Nauwelaers F Am J Clin Pathol; 2008 Apr; 129(4):649-56. PubMed ID: 18343793 [TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer. Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094 [TBL] [Abstract][Full Text] [Related]
11. Update on screening for prostate cancer with prostate-specific antigen. Schmid HP; Riesen W; Prikler L Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160 [TBL] [Abstract][Full Text] [Related]
12. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Beneduce L; Prayer-Galetti T; Giustinian AM; Gallotta A; Betto G; Pagano F; Fassina G Cancer Detect Prev; 2007; 31(5):402-7. PubMed ID: 18035503 [TBL] [Abstract][Full Text] [Related]
13. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes. Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115 [TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of prostatic specific antigen (PSA) in comparison to prostatic acid phosphatase (PAP) in prostatic cancer and adenoma]. Dutkiewicz S; Stepień K; Witeska A Wiad Lek; 1992 Oct; 45(19-20):750-3. PubMed ID: 1284261 [TBL] [Abstract][Full Text] [Related]
15. Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial. Määttänen L; Hakama M; Tammela TL; Ruutu M; Ala-Opas M; Juusela H; Martikainen P; Stenman UH; Auvinen A Br J Cancer; 2007 Jan; 96(1):56-60. PubMed ID: 17213825 [TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen kinetics in localized and advanced prostate cancer. Fitzpatrick JM; Banu E; Oudard S BJU Int; 2009 Mar; 103(5):578-87. PubMed ID: 19210674 [TBL] [Abstract][Full Text] [Related]
17. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis. Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862 [TBL] [Abstract][Full Text] [Related]
18. [Cancer of the prostate: advances in the use of PSA and its derived indices--new tumor markers]. Zlotta A; Schulman C Rev Med Brux; 1999 Sep; 20(4):A201-5. PubMed ID: 10523893 [TBL] [Abstract][Full Text] [Related]
19. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement. Bhuiyan AK; Kibria SA; Subhan SS Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483 [TBL] [Abstract][Full Text] [Related]
20. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity. Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]